{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:05:27Z","timestamp":1771455927588,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Florida State Live Like Bella Pediatric Cancer Research Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41375-023-01827-x","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:03:42Z","timestamp":1675361022000},"page":"934-937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MCL1 as a therapeutic vulnerability in Burkitt lymphoma"],"prefix":"10.1038","volume":"37","author":[{"given":"Ren","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfeng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-1594","authenticated-orcid":false,"given":"Jianguo","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"1827_CR1","unstructured":"Mohammad Muhsin Chisti HK, Yadav SK. B-cell lymphoma. MedScape2018. 2021. https:\/\/emedicine.medscape.com\/article\/202677-overview-a4."},{"key":"1827_CR2","doi-asserted-by":"publisher","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","volume":"4","author":"R Schmitz","year":"2014","unstructured":"Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM. Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med. 2014;4:a014282.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1827_CR3","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2007","unstructured":"Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109:2736\u201343.","journal-title":"Blood."},{"key":"1827_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1200\/JCO.2010.33.3369","volume":"30","author":"MS Cairo","year":"2012","unstructured":"Cairo MS, Sposto R, Gerrard M, Auperin A, Goldman SC, Harrison L, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (>\/= 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin\u2019s lymphoma: results of the FAB LMB 96 study. J Clin Oncol. 2012;30:387\u201393.","journal-title":"J Clin Oncol"},{"key":"1827_CR5","first-page":"685919","volume":"2012","author":"EF Miles","year":"2012","unstructured":"Miles EF, Jacimore LL. Synchronous bilateral breast carcinoma and axillary non-hodgkin lymphoma: a case report and review of the literature. Case Rep Oncol Med. 2012;2012:685919.","journal-title":"Case Rep Oncol Med"},{"key":"1827_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/bjh.13040","volume":"167","author":"S Goldman","year":"2014","unstructured":"Goldman S, Smith L, Galardy P, Perkins SL, Frazer JK, Sanger W, et al. Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/leukaemia: a Children\u2019s Oncology Group Report. Br J Haematol. 2014;167:394\u2013401.","journal-title":"Br J Haematol"},{"key":"1827_CR7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, et al. Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med. 2006;354:2431\u201342.","journal-title":"N Engl J Med"},{"key":"1827_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2141.2009.07967.x","volume":"148","author":"M Nelson","year":"2010","unstructured":"Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, et al. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children\u2019s Oncology Group study CCG-5961. Br J Haematol. 2010;148:600\u201310.","journal-title":"Br J Haematol"},{"key":"1827_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nri953","volume":"2","author":"AL Shaffer","year":"2002","unstructured":"Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol. 2002;2:920\u201332.","journal-title":"Nat Rev Immunol"},{"key":"1827_CR10","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, et al. A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419\u201330.","journal-title":"N Engl J Med"},{"key":"1827_CR11","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1038\/leu.2008.230","volume":"22","author":"W Klapper","year":"2008","unstructured":"Klapper W, Stoecklein H, Zeynalova S, Ott G, Kosari F, Rosenwald A, et al. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL). Leukemia. 2008;22:2226\u20139.","journal-title":"Leukemia."},{"key":"1827_CR12","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1182\/blood-2011-05-349662","volume":"119","author":"KE Deffenbacher","year":"2012","unstructured":"Deffenbacher KE, Iqbal J, Sanger W, Shen Y, Lachel C, Liu Z, et al. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood. 2012;119:3757\u201366.","journal-title":"Blood."},{"key":"1827_CR13","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/leu.2016.213","volume":"30","author":"Y Fernandez-Marrero","year":"2016","unstructured":"Fernandez-Marrero Y, Spinner S, Kaufmann T, Jost PJ. Survival control of malignant lymphocytes by anti-apoptotic MCL-1. Leukemia. 2016;30:2152\u20139.","journal-title":"Leukemia."},{"key":"1827_CR14","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1172\/JCI122533","volume":"128","author":"Y Ren","year":"2018","unstructured":"Ren Y, Bi C, Zhao X, Lwin T, Wang C, Yuan J, et al. PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas. J Clin Investig. 2018;128:5517\u201330.","journal-title":"J Clin Investig"},{"key":"1827_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ccell.2019.04.005","volume":"35","author":"X Zhao","year":"2019","unstructured":"Zhao X, Ren Y, Lawlor M, Shah BD, Park PMC, Lwin T, et al. BCL2 amplicon loss and transcriptional remodeling drives ABT-199 resistance in B cell lymphoma models. Cancer Cell. 2019;35:752\u201366.e9.","journal-title":"Cancer Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01827-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T11:05:10Z","timestamp":1680779110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01827-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-01827-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}